Comparison
9q31 1q31 3 Microdeletion Syndrome C4750910 vs Abnormal Amplitude Of Light Adapted Flicker Electroretinogram C4072969
Clinical comparison between 9q31 1q31 3 Microdeletion Syndrome and Abnormal Amplitude OF Light Adapted Flicker Electroretinogram for differential diagnosis and treatment planning.
9q31 1q31 3 Microdeletion Syndrome C4750910
A rare genetic condition from missing genetic material in a specific region of chromosome 9. May affect development, growth, and cause various medical concerns. Treatment focuses on symptom management and supportive therapies.
Abnormal Amplitude Of Light Adapted Flicker Electroretinogram C4072969
An abnormal eye test response to flickering light, which tests cone cell function. This finding may indicate problems with color vision cells and typically requires specialist eye evaluation.
6 comparison axes
Onset
9q31 1q31 3 Microdeletion Syndrome C4750910
Variable
Abnormal Amplitude Of Light Adapted Flicker Electroretinogram C4072969
Variable
Onset patterns differ
Severity
9q31 1q31 3 Microdeletion Syndrome C4750910
moderate
Abnormal Amplitude Of Light Adapted Flicker Electroretinogram C4072969
moderate
Different severity levels
Chronic
9q31 1q31 3 Microdeletion Syndrome C4750910
Chronic
Abnormal Amplitude Of Light Adapted Flicker Electroretinogram C4072969
Chronic
Differing course
Communicable
9q31 1q31 3 Microdeletion Syndrome C4750910
No
Abnormal Amplitude Of Light Adapted Flicker Electroretinogram C4072969
No
Different transmission
Body System
9q31 1q31 3 Microdeletion Syndrome C4750910
congenital
Abnormal Amplitude Of Light Adapted Flicker Electroretinogram C4072969
ophthalmologic
Same/different system
Category
9q31 1q31 3 Microdeletion Syndrome C4750910
genetic
Abnormal Amplitude Of Light Adapted Flicker Electroretinogram C4072969
genetic
Different category
Bottom line
9q31-1q31-3-microdeletion-syndrome-C4750910 and abnormal-amplitude-of-light-adapted-flicker-electroretinogram-C4072969 have similar characteristics
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 9q31 1q31 3 Microdeletion Syndrome C4750910 | Abnormal Amplitude Of Light Adapted Flicker Electroretinogram C4072969 | Discriminating power |
|---|---|---|---|
| Developmental pattern | May involve developmental, growth, or multisystem concerns from missing chromosome 9 material. | No developmental syndrome is implied by the ERG result alone. | High |
| Vision complaint | Eye involvement is not established from the supplied description. | Suggests abnormal cone response to flickering light; symptoms vary and may be absent. | High |
| Clinical category | A congenital genetic condition requiring supportive, symptom-based care. | An ophthalmologic finding that needs specialist correlation with history and examination. | High |
When to favor each condition
Choose 9q31 1q31 3 Microdeletion Syndrome C4750910 when
Confirmed chromosomal microarray or equivalent genetic result
The diagnosis depends on documented deletion in the 9q31.1-q31.3 region.
High
Unexplained developmental or growth concerns with genetic suspicion
Genetic evaluation is appropriate; this comparison does not establish diagnostic criteria.
Moderate
Need for coordinated supportive care
Management is individualized around identified medical and developmental needs.
Moderate
Choose Abnormal Amplitude Of Light Adapted Flicker Electroretinogram C4072969 when
Reported abnormal light-adapted flicker ERG amplitude
Use this label for the test finding itself, not as a disease name.
High
Suspected cone dysfunction
The flicker response assesses cone function, but confirmation needs full ophthalmic assessment.
Moderate
Isolated eye-test abnormality without genetic diagnosis
Do not infer a microdeletion syndrome from an ERG result alone.
High
How key tests differ
| Test | 9q31 1q31 3 Microdeletion Syndrome C4750910 | Abnormal Amplitude Of Light Adapted Flicker Electroretinogram C4072969 | Interpretation |
|---|---|---|---|
| Chromosomal microarray | May show a 9q31.1-q31.3 deletion when the syndrome is present. | Not expected to explain an isolated ERG abnormality. | Genetic confirmation and an ERG finding address different questions. |
| Light-adapted flicker ERG | No specific ERG pattern is established here. | Amplitude is abnormal by definition of the finding. | Abnormal amplitude indicates altered cone response, not a specific diagnosis. |
| Comprehensive eye examination | Indicated only if vision concerns or other findings are present. | Needed to correlate the ERG with acuity, color vision, and retinal findings. | Clinical context determines significance; cutoffs are not supplied. |
Prognosis comparison
9q31 1q31 3 Microdeletion Syndrome C4750910
- Outcome
- Variable and individualized; reliable outcome estimates are not established here.
- Factors
- Deletion details, associated findings, developmental support, and medical complications.
Abnormal Amplitude Of Light Adapted Flicker Electroretinogram C4072969
- Outcome
- Depends on the underlying eye condition, which this result does not identify.
- Factors
- Cause, degree of cone dysfunction, associated retinal findings, and follow-up.
Time frame: Long-term course may be chronic, but timing is not established.
Clinician correlation is essential; prevalence and mortality are not provided.
Complications comparison
| Complication | Presentation |
|---|---|
| Associated medical needs | Variable developmental, growth, or other concerns may occur. No systemic complication is established by the ERG finding alone. Exact complication rates are not established in the supplied data. |
| Visual function | Vision effects are not specified. May relate to cone or color-vision dysfunction, but severity varies. Specialist interpretation is required. |
| Diagnostic delay | Rare presentation may delay recognition without genetic testing. An isolated result may be overinterpreted without full evaluation. Neither label should be assigned from symptoms alone. |
Patient education highlights
- HighDifferent meanings
One is a rare genetic condition; the other is an abnormal eye-test result, not automatically a disease.
- HighSpecialist follow-up
Genetic or ophthalmology interpretation should guide next steps and avoid unsupported conclusions.
- MediumSupportive care
Care is individualized. No treatment dose or universal outcome can be inferred from these labels.